Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 18 matching records.
18 results — page 1 of 1
- Level BClinical TrialEurope PMC
Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Clinical Trial on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Front Cell Dev Biol (2025) — summary generated from the PubMed abstract.
- 2025
Front Cell Dev Biol15 citations - Level ASystematic ReviewEurope PMC
Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review
Systematic Review on Neuroinflammation, Immune Modulation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level ASystematic ReviewEurope PMC
Cell Therapy in Multiple Sclerosis: Clinical Advances, Limitations, and Future Perspectives from Clinical Studies-A Systematic Review
Systematic Review on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
- 2025
Pharmaceutics - Level DNarrative ReviewPubMed
Harnessing the therapeutic potential of mesenchymal stem/stromal cell-derived extracellular vesicles as a novel cell-free therapy for animal models of multiple sclerosis.
Narrative Review on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Exp Neurol (2023) — summary generated from the PubMed abstract.
- 2023
Exp Neurol - Level BClinical TrialPubMed
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series.
Clinical Trial on Neuroinflammation, published in Mult Scler Relat Disord (2022) — summary generated from the PubMed abstract.
- 2022
Mult Scler Relat Disord2 citations - Level BClinical TrialPubMed
Current advances in stem cell therapy in the treatment of multiple sclerosis.
Clinical Trial on Neuroinflammation, Immune Modulation, published in Rev Neurosci (2022) — summary generated from the PubMed abstract.
- 2022
Rev Neurosci - Level BClinical TrialEurope PMC
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
Clinical Trial on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Cell Mol Immunol (2021) — summary generated from the PubMed abstract.
- 2021
Cell Mol Immunol43 citations - Level DNarrative ReviewPubMed
Therapeutic Aspects of Mesenchymal Stem Cell-Based Cell Therapy with a Focus on Human Amniotic Epithelial Cells in Multiple Sclerosis: A Mechanistic Review.
Narrative Review on Neuroinflammation, Immune Modulation, published in Int J Stem Cells (2021) — summary generated from the PubMed abstract.
- 2021
Int J Stem Cells - Level DNarrative ReviewEurope PMC
The Role of Low-Level Laser Therapy in the Treatment of Multiple Sclerosis: A Review Study
Narrative Review on Neuroinflammation, Autoimmune Research, published in J Lasers Med Sci (2021) — summary generated from the PubMed abstract.
- 2021
J Lasers Med Sci6 citations - Level DNarrative ReviewPubMed
Safety and efficacy of stem cell therapy for treatment of neural damage in patients with multiple sclerosis.
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Stem Cell Investig (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Investig20 citations - Level BClinical TrialEurope PMC
Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis
Clinical Trial on Neuroinflammation, published in Cytotherapy (2018) — summary generated from the PubMed abstract.
- 2018
Cytotherapy33 citations - Level DAnimal StudyPubMed
Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.
Animal Study on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Br J Pharmacol (2017) — summary generated from the PubMed abstract.
- 2017
Br J Pharmacol - Level BClinical TrialPubMed
The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy.
Clinical Trial on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Arch Immunol Ther Exp (Warsz) (2017) — summary generated from the PubMed abstract.
- 2017
Arch Immunol Ther Exp (Warsz) - Level DNarrative ReviewEurope PMC
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Cell J (2017) — summary generated from the PubMed abstract.
- 2017
Cell J358 citations - Level BClinical TrialEurope PMC
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies
Clinical Trial on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Adv Biomed Res (2016) — summary generated from the PubMed abstract.
- 2016
Adv Biomed Res31 citations - Level DAnimal StudyPubMed
Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing-remitting multiple sclerosis model.
Animal Study on Neuroinflammation, Autoimmune Research, published in Stem Cell Res Ther (2014) — summary generated from the PubMed abstract.
- 2014
Stem Cell Res Ther8 citations - Level ASystematic ReviewEurope PMC
Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies
Systematic Review on Neuroinflammation, published in Int J Hematol Oncol Stem Cell Res (2013) — summary generated from the PubMed abstract.
- 2013
Int J Hematol Oncol Stem Cell Res14 citations - Level DNarrative ReviewPubMed
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in J Transl Med (2009) — summary generated from the PubMed abstract.
- 2009
J Transl Med189 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406